2M.D. Associate Professor, Beyoglu Training and Research Hospital, Eye Clinic, İstanbul/TURKEY
3M.D., Haydarpasa Numune Training and Research Hospital, Eye Clinic, İstanbul/TURKEY
4M.D., Denizli State Hospital, Eye Clinic, Denizli/TURKEY
5M.D., Professor, Beyoglu Training and Research Hospital, Eye Clinic, İstanbul/TURKEY Purpose: Our aim was to evaluate the efficacy and safety of endoscopic laser cyclophotocoagulation (ECP) in aphakic and pseudophakic glaucoma patients.
Materials and Methods: This retrospective case series comprised 53 eyes of 52 patients (36 males, 16 females) who underwent ECP. The types of glaucoma in the patients were as follows: primary open angle glaucoma (21 eyes, 39%), pseudoexfoliative glaucoma (10 eyes, 19%), secondary congenital glaucoma (6 eyes, 11%), neovascular glaucoma (5 eyes, 9%), glaucoma after pars plana vitrectomy (4 eyes, 8%), glaucoma after keratoplasty (3 eyes, 6%), glaucoma after blunt trauma to the eye (2 eyes, 4%) and glaucoma due to Sturge-Weber Syndrome (2 eyes, 4%).
Results: Patients' ages ranged from 3 to 80 years (mean age was 59.1±21.4 years). Mean follow-up time was 12.0 months (SD: 5,2). Mean preoperative intraocular pressure (IOP) was 24.6 (SD: 7.8) mmHg, and mean postoperative IOP at the last visit was 16.5 (SD: 5.1) mmHg (p<0.001). The average number of anti-glaucoma medications used by the patients decreased from 2.87 (SD: 0.98) to 2.13 (SD:1,26), (p<0.001). The success rate of the treatment was 83%.
Conclusions: ECP is a safe, effective, and repeatable procedure in aphakic and pseudophakic glaucoma patients. Its main advantage is in giving surgeons the opportunity to see ciliary bodies while photocoagulating them.
Keywords : Endoscopic laser cyclophotocoagulation, glaucoma, intraocular pressure